GlassScriptPhysician profile
Kenneth E Sparks
NPI 1427538826
$1,778.41
in general payments reported to CMS, 2019-2025
13 companies · $22.12 in 2025
The $22.12 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,064 · 2023: $693 · 2025: $22.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $377.70 | 2022-2025 | Ingrezza |
| Abbvie INC. | $315.88 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $230.87 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $188.54 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $152.21 | 2022-2023 | Austedo |
| Janssen Pharmaceuticals, INC | $125.00 | 2022 | |
| Axsome Therapeutics, INC. | $116.30 | 2023 | Auvelity |
| Alkermes, INC. | $83.68 | 2022 | |
| Sunovion Pharmaceuticals INC. | $72.93 | 2022 | |
| Lundbeck LLC | $49.48 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.26 | 2023 | Trintellix |
| Idorsia Pharmaceuticals US INC | $15.98 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $15.58 | 2023 | Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Sparks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.